---
schema_version: "secwatch.filing_event.v1"
accession: "0001062822-23-000030"
form_type: "8-K"
ticker: "LXRX"
cik: "0001062822"
company_name: "LEXICON PHARMACEUTICALS, INC."
filed_at: "2023-07-24T23:59:59+00:00"
generated_at: "2026-06-13T03:56:05.649734+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Director Frank P. Palantoni resigns from Lexicon board effective July 27, 2023

## Summary
- Frank P. Palantoni notified Lexicon of his resignation from the board on July 18, 2023.
- Resignation effective July 27, 2023; no disagreement with company operations or policies.
- Mr. Palantoni's departure is not due to any dispute with Lexicon.

## SEC filing metadata
- accession: 0001062822-23-000030
- form_type: 8-K
- ticker: LXRX
- cik: 0001062822
- company_name: LEXICON PHARMACEUTICALS, INC.
- filed_at: 2023-07-24T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1062822/000106282223000030/0001062822-23-000030-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1062822/000106282223000030/lxrx-20230718.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001062822-23-000030
- JSON: https://secwatch.observer/filing/0001062822-23-000030.json
- Plain text: https://secwatch.observer/filing/0001062822-23-000030.txt

## Key facts
- Executive change
  Frank P. Palantoni resigned as Director at LEXICON PHARMACEUTICALS, INC..
  - Action: resigned
  - Role: Director
  source text: On July 18, 2023, Frank P. Palantoni notified us of his decision to resign from our board of directors, effective July 27, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1062822/000106282223000030/0001062822-23-000030-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
